Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0461931419
Thu, 25.07.2024
Vitruvia Medical AG
Vitruvia Medical AG half-year results as of June 30, 2024
Vitruvia Medical AG achieves results as expected in the first half of 2024. The Board of Directors confirms the forecast for the year as a whole.
Vitruvia Medical AG is on target for the first six months of 2024. The result amounted to CHF -52,968.06 compared to CHF -150,464.24 in the p [ … ]
Wed, 01.05.2024
Vitruvia Medical AG
Vitruvia Medical AG: Year End results as of December 31, 2023
Anglikon, May 1st , 2024: Vitruvia Medical AG achieved a result after taxes of CHF -243,864.40 in the past year 2023 compared to CHF -1,095,349.38 in the previous year.
On a consolidated basis, Vitruvia Medical AG generated revenue of EUR 1,7575,724.00 (previous year: EUR 1,525,529.00) [ … ]
Wed, 01.05.2024
Vitruvia Medical AG
Vitruvia Medical AG: Year End results as of December 31, 2023
Anglikon, May 1st , 2024: Vitruvia Medical AG achieved a result after taxes of CHF -243,864.40 in the past year 2023 compared to CHF -1,095,349.38 in the previous year.
On a consolidated basis, Vitruvia Medical AG generated revenue of EUR 1,7575,724.00 (previous year: EUR 1,525,529.00) [ … ]
Fri, 29.09.2023
Vitruvia Medical AG
Consolidated interim results as per June 30th,2023
Vitruvia Medical AG achieves results as expected in the first half of 2023. The Board of Directors confirms the guidance for the full year.
Vitruvia Medical AG is on target in the first six months of 2023. The company generated consolidated revenues of approximately EUR 855,000.00 in the first h [ … ]
Sun, 25.06.2023
Vitruvia Medical AG
Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023
Anglikon, June 25, 2023: Vitruvia Medical AG reported net income after taxes of CHF -1,095,349.38 for the year ended December 31, 2022, compared to CHF -8,002,497.53 in the previous year.
On a consolidated basis, Vitruvia Medical AG generated revenues of EUR 1,525,529.-- and op [ … ]
Sun, 25.06.2023
Vitruvia Medical AG
Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023
Anglikon, June 25, 2023: Vitruvia Medical AG reported net income after taxes of CHF -1,095,349.38 for the year ended December 31, 2022, compared to CHF -8,002,497.53 in the previous year.
On a consolidated basis, Vitruvia Medical AG generated revenues of EUR 1,525,529.-- and op [ … ]
Mon, 27.03.2023
Vitruvia Medical AG
Ad Hoc Announcement
Anglikon, 27 March 2023: Vitruvia Medical AG has carried out an authorised capital increase as of today. Receivables in the amount of CHF 1'680'817.50 were offset, for which 672'327 registered shares at CHF 1.00 each were issued. The issue price was CHF 2.50 per registered share. The share capital of Vitruvia Medical AG now am [ … ]
Mon, 27.03.2023
Vitruvia Medical AG
Ad Hoc Announcement
Anglikon, 27 March 2023: Vitruvia Medical AG has carried out an authorised capital increase as of today. Receivables in the amount of CHF 1'680'817.50 were offset, for which 672'327 registered shares at CHF 1.00 each were issued. The issue price was CHF 2.50 per registered share. The share capital of Vitruvia Medical AG now am [ … ]
Sat, 26.11.2022
Vitruvia Medical AG
Convertible bond Vitruvia Medical AG ("Private Placement") 6.00% 2022-2025
By resolution of the Board of Directors, Vitruvia Medical AG has resolved to issue a convertible bond ("Private Placement") of CHF 2.2 million at an interest rate of 6.00% p.a. and a term of 3 years. The issue price is set at 100% and the conversion price is EUR 2 [ … ]
Sat, 26.11.2022
Vitruvia Medical AG
Convertible bond Vitruvia Medical AG ("Private Placement") 6.00% 2022-2025
By resolution of the Board of Directors, Vitruvia Medical AG has resolved to issue a convertible bond ("Private Placement") of CHF 2.2 million at an interest rate of 6.00% p.a. and a term of 3 years. The issue price is set at 100% and the conversion price is EUR 2 [ … ]